FDA Announces Draft Guidance on Pharmacy Compounding of Human Drug Products and Withdraws Outdated Guidance

Summary

The Food and Drug Administration (FDA) is releasing a draft guidance on regulating pharmacy compounding of human drugs, replacing outdated guidance and reflecting the agency's current thinking on the issue, following the amendment of the Federal Food, Drug, and Cosmetic Act by the Drug Quality and Security Act.